Caption Management’s Ionis Pharmaceuticals IONS Stock Holding History

Caption Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.4M	Buy	+345,900	New	+$26M	0.13%	166
2026 Q1	–	Sell	-60,000	Closed	-$4.75M	–	1794
2025 Q4	$4.75M	Buy	60,000 +15,000	+33%	+$1.13M	0.03%	537
2025 Q3	$2.94M	Sell	45,000 -15,000	-25%	-$732K	0.02%	677
2025 Q2	$2.37M	Buy	60,000 +30,000	+100%	+$982K	0.03%	672
2025 Q1	$905K	Buy	+30,000	New	+$982K	0.01%	955
2024 Q4	–	Sell	-60,000	Closed	-$2.4M	–	1637
2024 Q3	$2.4M	Sell	60,000 -30,000	-33%	-$1.4M	0.04%	508
2024 Q2	$4.29M	Buy	+90,000	New	+$3.69M	0.07%	294
2023 Q4	–	Sell	-30,000	Closed	-$1.36M	–	1502
2023 Q3	$1.36M	Sell	30,000 -30,000	-50%	-$1.24M	0.02%	688
2023 Q2	$2.46M	Hold	60,000	–	–	0.04%	443
2023 Q1	$2.14M	Buy	60,000 +30,000	+100%	+$1.13M	0.04%	428
2022 Q4	$1.13M	Hold	30,000	–	–	0.02%	705
2022 Q3	$1.33M	Buy	+30,000	New	+$1.26M	0.02%	773
2022 Q1	–	Sell	-57,500	Closed	-$1.75M	–	1692
2021 Q4	$1.75M	Hold	57,500	–	–	0.02%	835
2021 Q3	$1.93M	Sell	57,500 -125,800	-69%	-$4.74M	0.02%	773
2021 Q2	$7.31M	Buy	183,300 +153,300	+511%	+$6M	0.1%	270
2021 Q1	$1.35M	Sell	30,000 -134,600	-82%	-$7.51M	0.03%	617
2020 Q4	$9.31M	Buy	164,600 +61,600	+60%	+$3.07M	0.21%	131
2020 Q3	$4.89M	Buy	103,000 +3,000	+3%	+$167K	0.11%	222
2020 Q2	$5.9M	Buy	+100,000	New	+$5.56M	0.2%	137
2019 Q3	–	Sell	-50,300	Closed	-$3.23M	–	797
2019 Q2	$3.23M	Sell	50,300 -54,700	-52%	-$3.87M	0.16%	177
2019 Q1	$8.52M	Buy	+105,000	New	+$6.77M	0.47%	54

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Caption Management's IONS Position: Q2 2026 in Review

Caption Management reduced its Ionis Pharmaceuticals (IONS) stake by 89% in Q2 2026, selling an estimated $1.04M and leaving 1,759 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

Caption Management first reported a position in IONS in Q2 2020 and has held it in 13 quarters since. The position peaked at $9.33M in Q2 2020. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Caption Management held 1,759 shares of Ionis Pharmaceuticals worth $139K as of Q2 2026.
Caption Management sold 13,832 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.04M.
Ionis Pharmaceuticals made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1504 holding.
Caption Management first reported a position in Ionis Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
Caption Management's Ionis Pharmaceuticals position peaked at $9.33M in Q2 2020.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.